James Peyer is CEO and Founder of Cambrian Biopharma, which is bridging the gap between academic discovery and drug development
Read More
Financing for Cambrian co-led by Anthos Capital and SALT Fund; Anthos's Paul Farr and biotech leader Brent Saunders to join board of directors
Read More